Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

How the US CRISPR patent probe will play out

Nature volume 531, page 149 (2016)Cite this article

Subjects

Decision could determine who profits from the gene-editing technique in future.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Heidi Ledford
    View author publications

    You can also search for this author inPubMed Google Scholar

Additional information

Tweet Facebook LinkedIn Weibo

Related links

Related links

Related links in Nature Research

Bitter fight over CRISPR patent heats up 2016-Jan-12

CRISPR, the disruptor 2015-Jun-03

Chinese scientists genetically modify human embryos 2015-Apr-22

CRISPR technology leaps from lab to industry 2013-Dec-03

Nature special: CRISPR

Related external links

US Patent and Trademark Office

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ledford, H. How the US CRISPR patent probe will play out. Nature 531, 149 (2016). https://doi.org/10.1038/531149a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/531149a

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research